Fig. 4

Boxplots: composite endpoint. Boxplots showing bio-ADM and IL-6 in COVID-19 patients who were admitted to the ICU and/or died during their in-hospital stay. A Bio-ADM is significantly elevated in COVID-19 patients who reached the composite endpoint compared to those who did not (p < 0.001). The Median of bio-ADM regarding COVID-19 patients who reached the composite endpoint and those who did not was 58.8 pg/nl and 30.4 pg/nl. B IL-6 is significantly elevated in COVID-19 patients who reached the composite endpoint compared to those who did not (p < 0.001). The Median of IL-6 regarding COVID-19 patients who reached the composite endpoint and those who did not was 107.5 pg/nl and 26.5 pg/nl